| Revenue growth | 15% YoY for FY26; 11% YoY for Q4. |
|---|---|
| Margins | Expanding; FY26 margins up 68 bps to 18.5%. |
| Demand visibility | Resilient demand for high-quality oncology care across all modalities. |
| Management confidence | High, emphasizing scalability and depth of clinical capabilities. |
Growth
Revenue grew 15% to ₹25,454 mn; Q4 Adjusted PAT surged 363% YoY on low base.
Outlook
Completed ₹4,250 mn rights issue to fund capacity expansion and technology upgrades.
Risks
Potential impact of new labor codes and impairment of goodwill mentioned as one-time exceptional items.
Earnings Call filed with NSE, NSE: HCG. Summary written with AI assistance from the document.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹698.65
- Market cap
- ₹10,431 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 457.5×Sector 57.8×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Annual General Meeting
HealthCare Global Enterprises held its 28th Annual General Meeting on September 18, 2026, via video conferencing to transact business items listed in the notice.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global Enterprises Limited granted 64,46,843 employee stock options under its ESOS 2026 scheme. The grant carries an exercise price of INR 495 per share.
Healthcare Global Enterprises Earnings Call Transcript: Key Takeaways
HCG reported a strong Q1FY27 with 13% YoY revenue growth and 20% EBITDA growth, driven by volume and improved payor mix.
Healthcare Global Enterprises Investor Presentation: Key Takeaways
HCG reported strong Q1 FY27 results with 13% YoY revenue growth and 20% Adjusted EBITDA growth. Strategic focus on oncology and capacity expansion through a new North Bengaluru facility.
Healthcare Global Enterprises Q1 FY27 Results: Net Profit ₹16.5 Cr, Up 175.0% YoY
Healthcare Global Enterprises Ltd reported revenue from operations of ₹693.4 Cr (+13.3% YoY) and net profit of ₹16.5 Cr (+175.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹16.5 Cr · +175.0% YoY
Healthcare Global Enterprises Earnings Call: Key Takeaways
HCG delivered strong FY26 performance with 15% revenue growth and margin expansion. Strategy focuses on oncology core through the sale of fertility unit Milann and brownfield expansion.